Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Role of CCN3 on Hs578T triple negative breast cancer cell line
GEO Series GSE193382. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
H3K27me3 conditions chemotolerance in triple-negative breast cancer [scChIP-seq]
GEO Series GSE164385. Homo sapiens. 13 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Targeting the SIN3A-PF1 Interaction inhibits Epithelial to Mesenchymal Transition and Maintenance of a Stem Cell Phenotype in Triple Negative Breast Cancer
GEO Series GSE73871. Homo sapiens. 9 samples. Type: Expression profiling by array; Methylation profiling by high throughput sequencing.
TLR4-dependent fibroblast-monocyte axis in tumor-draining lymph nodes contributes to metastasis in triple-negative breast cancer
GEO Series GSE267533. Mus musculus. 6 samples. Type: Expression profiling by high throughput sequencing.
Oncogenic transcription factors instruct promoter-enhancer hubs in individual triple negative breast cancer cells [RNA-seq]
GEO Series GSE264707. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
The CXCL10/CXCR3 axis is essential for sustaining immunological dormancy in triple-negative breast cancer
GEO Series GSE304626. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
Regulation of ribosomal gene expression and senescence by a PML-mTOR-RONIN nuclear complex in triple-negative breast cancer [RNA-seq_shPML]
GEO Series GSE283106. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
The inhibitory effects of Propofol and (-)-Epigallocatechin-3-gallate on the growth of human triple negative breast cancer MDA.MB231 cells.
<p><strong>Figure 1. MDA.MB231 cells migration is inhibiteb by Propofol and EGCG. </strong>MDA.MB231 cells were incubated in medium alone <strong>A); B) </strong>Propofol 10 μg/ml, <strong>C)</strong> EGCG 40 μM , <strong>D)</strong> Propofol 10 μg/ml and EGCG 40 μM. At 48 h <strong>(D)</strong> the inhibitory effect of EGCG and TAP, was clearly evident (*<em>P value</em> < 0.05).</p>
ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT04975451. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Eribulin Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT04517292. IPD Sharing: Not stated. Countries: 1. Publications: 0.
OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05949021. IPD Sharing: NO. Countries: 1. Publications: 0.
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06492759. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT
ClinicalTrials.gov study NCT04137653. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
ClinicalTrials.gov study NCT06841354. IPD Sharing: YES. Countries: 33. Publications: 0.
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT07173751. IPD Sharing: NO. Countries: 1. Publications: 0.
Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT02393794. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02089854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04947189. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT05447702. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitab
ClinicalTrials.gov study NCT01333137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.